Regulation And Legal
PTC Therapeutics Director Sells $1.35M Shares
Director Michael Schmertzler sold 20,000 PTC Therapeutics shares for about $1.35 million via a Rule 10b5‑1 plan on September 16‑17 2026.
The transactions were executed at weighted average prices of $6
